A rational approach to dose optimisation of pembrolizumab and nivolumab using cost analysis and pharmacokinetic modelling and simulation.
Ogungbenro, K Patel, Alkesh Duncombe, Robert Clark, James Lorigan, Paul C
Ogungbenro, K
Patel, Alkesh
Duncombe, Robert
Clark, James
Lorigan, Paul C
Citations
Altmetric:
Abstract
Description
Date
2016-10-01
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
A rational approach to dose optimisation of pembrolizumab and nivolumab using cost analysis and pharmacokinetic modelling and simulation. 2016, 27(suppl_6):1082P Annals of Oncology